14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ADAMH vs PMTW: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Adamas Trust, Inc. 9.875% Senior Notes Due 2030 (ADAMH) is the stronger overall head-to-head candidate over PennyMac Mortgage Investment Trust 9.00% Senior Notes due 2030 (PMTW) in the Tradestie Institutional Equity Comparison Engine, winning 4–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). ADAMH carries a Unified Composite Score of 37.1/100 (SELL) at $23.90 (N/M Forward P/E, -13.8% operating margin), whereas PMTW carries 39.0/100 (SELL) at $24.23 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While PMTW currently prints a higher short-term Unified Composite Score (39.0/100 SELL vs. ADAMH 37.1/100 SELL), ADAMH captures the overall institutional head-to-head verdict (4–2 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (-13.8% vs. N/A operating margin) and revenue trajectory (+129.8% vs. N/A YoY).
Defensive Composite Rating Caution: Although ADAMH compares more favorably head-to-head, both ADAMH (37.1/100 SELL) and PMTW (39.0/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: ADAMH is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.0); meanwhile PMTW is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 21.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ADAMH vs PMTW. Trailing 12-month operating profitability (ADAMH -13.8% vs PMTW N/A) and valuation multiples (ADAMH N/M vs PMTW N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Real Estate Investment Trusts value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ ADAMH vs PMTW Key Questions & Quantitative Answers
As of Nov 20, 2026, Adamas Trust, Inc. 9.875% Senior Notes Due 2030 (ADAMH) is the stronger overall head-to-head candidate over PennyMac Mortgage Investment Trust 9.00% Senior Notes due 2030 (PMTW) in the Tradestie Institutional Equity Comparison Engine, winning 4–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). ADAMH carries a Unified Composite Score of 37.1/100 (SELL) at $23.90 (N/M Forward P/E, -13.8% operating margin), whereas PMTW carries 39.0/100 (SELL) at $24.23 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While PMTW currently prints a higher short-term Unified Composite Score (39.0/100 SELL vs. ADAMH 37.1/100 SELL), ADAMH captures the overall institutional head-to-head verdict (4–2 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (-13.8% vs. N/A operating margin) and revenue trajectory (+129.8% vs. N/A YoY). Defensive Composite Rating Caution: Although ADAMH compares more favorably head-to-head, both ADAMH (37.1/100 SELL) and PMTW (39.0/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: ADAMH is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.0); meanwhile PMTW is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 21.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ADAMH leads the Growth & Scale pillar: ADAMH posts +129.8% YoY revenue growth and +21.2% YoY earnings growth on $172M TTM revenue (55.0% gross margin, -13.8% operating margin), compared with PMTW at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, ADAMH generates $172M in USD-normalized revenue versus N/A for PMTW. In operating R&D and SG&A reinvestment, ADAMH deploys 68.8% of Rev ($118M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for PMTW.
ADAMH and PMTW trade at balanced relative valuation multiples. ADAMH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas PMTW trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ADAMH (2.5% ROE) versus PMTW (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, ADAMH carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.11β · 8% Vol realized risk). By comparison, PMTW carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.09β · 5% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.